ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 81 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,022,565 | -22.0% | 169,019 | 0.0% | 0.00% | – |
| Q2 2023 | $1,311,587 | +74.2% | 169,019 | +49.9% | 0.00% | – |
| Q1 2022 | $753,000 | -42.6% | 112,748 | +1.4% | 0.00% | – |
| Q4 2021 | $1,312,000 | -56.4% | 111,159 | -6.8% | 0.00% | -100.0% |
| Q3 2021 | $3,007,000 | +47.5% | 119,217 | +3.5% | 0.00% | 0.0% |
| Q2 2021 | $2,038,000 | +13.7% | 115,198 | +57.4% | 0.00% | 0.0% |
| Q1 2021 | $1,793,000 | -22.1% | 73,198 | +7.7% | 0.00% | 0.0% |
| Q4 2020 | $2,302,000 | +172.1% | 67,996 | +100.9% | 0.00% | – |
| Q3 2020 | $846,000 | -25.6% | 33,844 | +0.4% | 0.00% | – |
| Q2 2020 | $1,137,000 | – | 33,693 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |